Heavner MS et al. |
Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. |
2013 |
Am J Health Syst Pharm |
pmid:23943182
|
Bonhomme-Faivre L et al. |
Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. |
2009 |
Am J Health Syst Pharm |
pmid:19729569
|
Lee JH et al. |
Stability of tacrolimus solutions in polyolefin containers. |
2016 |
Am J Health Syst Pharm |
pmid:26796907
|
|
Tacrolimus. |
2001 |
Am J Health Syst Pharm |
pmid:11794952
|
Lee B et al. |
Appropriate timing of tacrolimus concentration measurements in the emergency department. |
2016 |
Am J Health Syst Pharm |
pmid:27543574
|
Jacobson PA et al. |
Stability of tacrolimus in an extemporaneously compounded oral liquid. |
1997 |
Am J Health Syst Pharm |
pmid:9117806
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Johnson CE et al. |
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration. |
1999 |
Am J Health Syst Pharm |
pmid:10030533
|
Pennington CA and Park JM |
Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. |
2015 |
Am J Health Syst Pharm |
pmid:25631834
|
Tsapepas DS et al. |
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient. |
2011 |
Am J Health Syst Pharm |
pmid:21200061
|
Kasper RC et al. |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease. |
2001 |
Am J Dermatopathol |
pmid:11285407
|
Gupta AK and Versteeg SG |
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. |
2017 |
Am J Clin Dermatol |
pmid:27804089
|
Yang LP and Curran MP |
Spotlight on topical pimecrolimus in pediatric atopic dermatitis. |
2010 |
Am J Clin Dermatol |
pmid:20509720
|
Mertens JS et al. |
Morphea and Eosinophilic Fasciitis: An Update. |
2017 |
Am J Clin Dermatol |
pmid:28303481
|
Kroft EB et al. |
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. |
2009 |
Am J Clin Dermatol |
pmid:19354332
|
Wellington K and Noble S |
Pimecrolimus: a review of its use in atopic dermatitis. |
2004 |
Am J Clin Dermatol |
pmid:15663345
|
Lübbe J et al. |
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice. |
2006 |
Am J Clin Dermatol |
pmid:16605292
|
Ellis CN et al. |
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of age. |
2006 |
Am J Clin Dermatol |
pmid:16605293
|
Wollina U |
The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. |
2007 |
Am J Clin Dermatol |
pmid:17492844
|